Whole Body Magnetic Resonance Imaging

DIAGNOSTIC_TEST2 trials

Sponsors

East and North Hertfordshire NHS Trust, Johns Hopkins University

Conditions

Atypical NeurofibromaMalignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis)Metastatic Breast CancerNeurofibromatosis 1

Unknown Phase

Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to the Bone: A Whole Body MRI Study

East and North Hertfordshire NHS TrustMetastatic Breast Cancer

Start: 2016-04-21End: 2018-05-31Target: 40Updated: 2017-08-30

Multi-parametric Biomarker Development to Predict Malignant Conversion in Patients With Neurofibromatosis Type 1

Active, not recruitingNCT05677594

Johns Hopkins UniversityAtypical Neurofibroma, Malignant Peripheral Nerve Sheath Tumor (MPNST) of Soft Tissue (Diagnosis), Neurofibromatosis 1

Start: 2021-07-01End: 2028-06-30Updated: 2026-01-12

Related Papers

Comparison of Whole-Body MRI, CT, and Bone Scintigraphy for Response Evaluation of Cancer Therapeutics in Metastatic Breast Cancer to Bone

Radiology2020-10-2036 citations

Response evaluation of cancer therapeutics in metastatic breast cancer to the bone: A single arm phase II study of whole-body magnetic resonance imaging

Annals of Oncology2018-10-01